WCAS sells Aptuit to Evotec for about $300 mln

Welsh, Carson, Anderson & Stowe has sold drug developer Aptuit to Evotec AG for about $300 million. Cravath, PWC, Cain Brothers and William Blair advised Aptuit on the deal while Evotec's advisers included Freshfields Bruckhaus Deringer, KPMG, Mercer and Rothschild.

DealsNorth AmericaUSBriefs